Thomas Parker

Thomas Parker currently serves as the Senior Scientist and Head of MSAT at BridgeBio since December 2020. Prior to this role, Thomas led a global team at MilliporeSigma focused on vaccines and viral therapies, advancing bioprocessing efforts while addressing industry gaps through scientific collaboration. Experience includes downstream purification process development for various biopharmaceuticals and engagement in pilot-scale purification projects at Biogen. Thomas holds a Bachelor's Degree in Chemical and Biomolecular Engineering with a concentration in Biomanufacturing Sciences from North Carolina State University.